Product Information
VYTORIN 10-20 MG TABLET is a brand product labeled by Organon LLC, priced at $13.6206 per EA under NDC 78206017502. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Jul 23, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the ezetimibe and simvastatin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10; 20 mg/1; mg/1
Manufacturer
Organon LLCNDC
78206017502
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
EZETIMIBE; SIMVASTATINApproval Type
New Drug (NDA)
FDA Application
NDA021687FDA Approved
7/23/2004
TE Code
AB
On Market Since
6/1/2021
Pharmacological Classes
Price Statistics
The NADAC for VYTORIN 10-20 MG TABLET has been published 123 times since Apr 17, 2024, and over the history we have for it it has risen 8.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.6206 per EA |
|---|---|
| All-time high | $13.8891 (Aug 12, 2026) |
| All-time low | $12.5269 (Apr 17, 2024) |
| 52-week high | $13.8891 |
| 52-week low | $13.2126 |
| Median price | $13.2126 |
| Average price | $13.2005 |
| Largest weekly change | +5.0% (Jan 1, 2025) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VYTORIN 10-20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VYTORIN 10-20 MG TABLET, manufactured by Organon LLC, is $13.6206 per EA (NDC 78206017502), effective Aug 19, 2026.
How has the price of VYTORIN 10-20 MG TABLET changed over time?
Over the history we have for it, the NADAC for VYTORIN 10-20 MG TABLET has risen 8.7%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for VYTORIN 10-20 MG TABLET?
Since Apr 17, 2024, the NADAC for VYTORIN 10-20 MG TABLET has ranged from a low of $12.5269 (Apr 17, 2024) to a high of $13.8891 (Aug 12, 2026), with a median of $13.2126 per EA.
Are there cheaper alternatives to VYTORIN 10-20 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EZETIMIBE-SIMVASTATIN 10-20 MG, is $0.2278 per EA — about 98% below VYTORIN 10-20 MG TABLET.
Who manufactures VYTORIN 10-20 MG TABLET?
VYTORIN 10-20 MG TABLET (NDC 78206017502) is labeled by Organon LLC, and CMS classifies it as a brand product.